Skip to main content
Premium Trial:

Request an Annual Quote

Roche, Fluidigm Ink Deal to Co-market Access Array Platform with 454 Sequencing


By Justin Petrone

Fluidigm and Roche 454 Life Sciences this week announced that they have entered a worldwide co-promotional agreement that pairs Fluidigm's amplicon sample-preparation platform with Roche 454's high-throughput sequencers.

The partners will market Fluidigm’s Access Array System for use in target enrichment prior to sequencing on Roche 454's GS Junior or GS FLX System.

Launched last year, Access Array enables automated processing of 48 samples against 48 amplicons, resulting in PCR products that are ready for emPCR amplification. Amplicon sample preparation can take weeks using traditional approaches, the firms noted.

In addition to sequencing library preparation using amplicon tagging, the integrated fluidic circuit-based platform supports sample capture and target enrichment and sample barcoding for multiplexed sequencing, according to South San Francisco, Calif.-based Fluidigm.

454 CEO and President Christopher McLeod said the Access Array System and GS Junior are "extremely complementary," and enable the analysis of "large numbers of sample/amplicon combinations in an affordable workflow without the need for complicated liquid handling."

A single Access Array plate on a single GS Junior System run "generates as much data as hundreds, even thousands, of 96-well plates analyzed on a capillary sequencing system," McLeod said.

Financial terms of the deal were not discussed.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.